Biomarin Pharmaceutical Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 22 trades in Biomarin Pharmaceutical Inc (NASDAQ: BMRN) since 2014, across 9 members, worth an estimated $339.18K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 11 buys against 11 sells, an evenly split skew, with Democratic members responsible for 77% of the trades and Republican members 23%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Biomarin Pharmaceutical Inc's current Quantellect Tide Score is 46 out of 100 (Calm Tide), Bottom 44% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Biomarin Pharmaceutical Inc (BMRN) stock overview and the complete trade table below.
Price & congressional trade timeline
Party breakdown
Biomarin Pharmaceutical congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
| No congressional trades in this period. | ||||||||
Biomarin Pharmaceutical (BMRN) congressional trading FAQ
Can members of Congress legally trade Biomarin Pharmaceutical (BMRN) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Biomarin Pharmaceutical (BMRN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Biomarin Pharmaceutical (BMRN) trades public?
Yes. Every congressional trade in Biomarin Pharmaceutical (BMRN) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Biomarin Pharmaceutical (BMRN)?
Members of Congress have disclosed 22 trades in Biomarin Pharmaceutical (BMRN) worth $339.18K across 9 members, according to public STOCK Act filings.
Do Democrats or Republicans trade Biomarin Pharmaceutical (BMRN) more?
Across disclosed Biomarin Pharmaceutical (BMRN) trades, 77% were by Democrats and 23% by Republicans, led by Democrats (77%).
What is Biomarin Pharmaceutical (BMRN)'s Tide Score?
Biomarin Pharmaceutical (BMRN) has a Quantellect Tide Score of 46 (Calm Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewBiomarin Pharmaceutical (BMRN) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.